Direct Oral Anticoagulants (DOACs) have simplified the treatment of thromboembolic
disease. In addition to their established anticoagulant effects, there are indications from …

Peripheral artery disease (PAD) is caused by occluded or narrowed arteries that reduce
blood flow to the lower limbs. The treatment focuses on lifestyle changes, management of …

Cardiovascular disease (CVD) has a high incidence and low cure rate worldwide, and
atherosclerosis (AS) is the main factor inducing cardiovascular disease, of which lipid …

Objective Consumptive coagulopathy treatment and pain management are crucial for
patients with venous malformations (VMs). Dabigatran etexilate, a non–vitamin K antagonist …

Non-vitamin K oral anticoagulants (NOACs) have revolutionized anticoagulant therapy,
offering improved safety and efficacy over traditional agents like warfarin. This review …

Oral anticoagulant therapy (OAT) for managing atrial fibrillation (AF) encompasses vitamin K
antagonists (VKAs, such as warfarin), which was the mainstay of anticoagulation therapy …